Literature DB >> 25716545

Correlation of myelodysplastic syndromes with i(17)(q10) and TP53 and SETBP1 mutations.

Vera Adema1,2, María J Larráyoz3, María J Calasanz3, Laura Palomo1, Ana Patiño-García4, Xabier Agirre5, Jesús M Hernández-Rivas6, Eva Lumbreras6, Ismael Buño7, Carolina Martinez-Laperche7, Mar Mallo1, Olga García1, Sara Álvarez8, Beatriz Blazquez9, José Cervera10, Elisa Luño11, Alberto Valiente12, María T Vallespí13, Leonor Arenillas14, Rosa Collado15, Jaime Pérez-Oteyza16, Francesc Solé17.   

Abstract

Entities:  

Keywords:  SETBP1; TP53; i(17)(q10); myelodysplastic syndromes

Mesh：

Substances：

Year:  2015        PMID： 25716545     DOI： 10.1111/bjh.13355

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

Review 1.  Somatic SETBP1 mutations in myeloid neoplasms.

Authors:  Hideki Makishima
Journal:  Int J Hematol       Date:  2017-04-26       Impact factor: 2.490

Review 2.  Genetic Aspects of Myelodysplastic/Myeloproliferative Neoplasms.

Authors:  Laura Palomo; Pamela Acha; Francesc Solé
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

3.  Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis.

Authors:  Li-Hong Shou; Dan Cao; Xiao-Hui Dong; Qiu Fang; Ying Wu; Yan Zhang; Ju-Ping Fei; Bao-Lian Xu
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240

4.  Myeloid Neoplasms with Isolated Isochromosome 17q: a yet to be Defined Entity.

Authors:  Eleftheria Lamprianidou; Chryssoula Kordella; Menelaos Papoutselis; Zoi Bezyrgiannidou; Evangelia Nakou; Spyros Papamichos; Emmanouil Spanoudakis; Andreas Giannopoulos; Katerina Zoi; Ioannis Kotsianidis
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-11-01       Impact factor: 2.576

5.  Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group.

Authors:  Rashmi Kanagal-Shamanna; Attilio Orazi; Robert P Hasserjian; Daniel A Arber; Kaaren Reichard; Eric D Hsi; Adam Bagg; Heesun Joyce Rogers; Julia Geyer; Faezeh Darbaniyan; Kim-Anh Do; Kyle M Devins; Olga Pozdnyakova; Tracy I George; Paola Dal Cin; Patricia T Greipp; Mark J Routbort; Keyur Patel; Guillermo Garcia-Manero; Srdan Verstovsek; L Jeffrey Medeiros; Sa A Wang; Carlos Bueso-Ramos
Journal:  Mod Pathol       Date:  2021-11-13       Impact factor: 7.842

6.  Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS.

Authors:  Rashmi Kanagal-Shamanna; Rajyalakshmi Luthra; Cameron C Yin; Keyur P Patel; Koichi Takahashi; Xinyan Lu; John Lee; Chong Zhao; Francesco Stingo; Zhuang Zuo; Mark J Routbort; Rajesh R Singh; Patricia Fox; Farhad Ravandi; Guillermo Garcia-Manero; L Jeffrey Medeiros; Carlos E Bueso-Ramos
Journal:  Oncotarget       Date:  2016-03-22

Review 7.  SETBP1 dysregulation in congenital disorders and myeloid neoplasms.

Authors:  Nicoletta Coccaro; Giuseppina Tota; Antonella Zagaria; Luisa Anelli; Giorgina Specchia; Francesco Albano
Journal:  Oncotarget       Date:  2017-04-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.